Use
The IPS was derived from 5,141 patients with advanced Hodgkin lymphoma; each factor reduced 5-year freedom from progression by about 7–8% [1]. Treatment is now mostly adapted by interim PET, but the IPS is still used when choosing between ABVD, BV-AVD and BEACOPP and for trial entry. Regimens: ABVD, BV-AVD.
Related cancer types
Treatment regimens (physicians)
Physician tools and lessons
References
1 referenceShow all referencesClose the reference list
Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.
- 1A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease
This page is based on reputable scientific sources and was last updated on 27 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.
Printed from the website; the full and up-to-date version: https://drdabiri.com/en/tools/hodgkin-ips-calculator/